CTD O 12.5/40 (Olmesartan Medoxomil (40mg) + Chlorthalidone (12.5mg))

CTD-O 12.5/40 Tablet is a formulation that combines two distinct medications to assist in managing high blood pressure through various mechanisms. Untreated high blood pressure can lead to serious cardiovascular complications such as heart attacks, strokes, and kidney failure. This medication can be taken with or without food, and the prescribed dosage will vary based on your individual health condition and response to treatment. It is advisable to take the tablet at the same time each day to maintain consistent levels in the body. Continuous use is important until your healthcare provider instructs otherwise. One of the components of this medication is a diuretic, which increases urination; therefore, it is recommended to avoid taking it within four hours of bedtime to mitigate nighttime disruptions. Regular consumption is crucial for optimal results, even if you feel well, as high blood pressure often presents without noticeable symptoms. Abruptly discontinuing the medication may elevate the risk of serious health events like heart attacks or strokes. While dizziness is a frequent side effect, other possible effects include fatigue, nausea, diarrhea, headaches, and lowered blood pressure. Increased urination is expected due to the diuretic effect and not classified as a side effect. Rare side effects may occur, and it is essential to review the accompanying information leaflet and consult your healthcare provider if side effects are concerning or persist. This medication is not typically advised for pregnant patients, and those with kidney or liver conditions, heart issues, or diabetes should seek medical advice before use. Alcohol consumption can further reduce blood pressure and may enhance side effects.